MILWAUKEE, March 5, 2013 (GLOBE NEWSWIRE) -- We are investigating possible securities fraud claims against Impax Laboratories, Inc. resulting from inaccurate statements the Company made regarding its financial performance, manufacturing processes, and future prospects.
Click here to learn how to learn more about the investigation: http://www.ademilaw.com/case/impax-laboratories-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.
Our investigation focuses on whether Impax misrepresented that its Hayward manufacturing facility complied with regulatory requirements. On March 4, 2013, the Federal Drug Administration issued a Form 483 notice of non-compliance for the Hayward facility with respect to Impax's analytical method validation and stability data, and its general Good Manufacturing Practices.
If you wish to obtain additional information, please contact Guri Ademi either at email@example.com or toll-free: 866-264-3995, http://www.ademilaw.com/case/impax-laboratories-inc.
We specialize in securities fraud and shareholder litigation. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Ademi & O'Reilly, LLP Guri Ademi 3620 East Layton Ave. Cudahy, WI 53110 Toll Free: (866) 264-3995 Fax: (414) 482-8001 www.ademilaw.comSource:Ademi & O'Reilly, LLP